Credit Suisse's Catherine Arnold cuts earnings forecasts for Merck (MRK -6.5%) but says she...

|About: Merck & Co Inc. (MRK)|By:, SA News Editor

Credit Suisse's Catherine Arnold cuts earnings forecasts for Merck (MRK -6.5%) but says she would buy shares on the dip after the company revealed problems in clinical trials with a drug designed to prevent blood clots. Merck has other attractive drugs in its pipeline, she says, and integration of Schering-Plough will help it grow EPS at a pace faster than its peers.